# A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

> **NCT00293787** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 156 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Travoprost 0.004% / Timolol 0.5% Ophthalmic Solution
- **OTHER:** Timolol Vehicle
- **DRUG:** Latanoprost 0.005% Ophthalmic Solution (XALATAN)
- **DRUG:** Timolol Maleate Ophthalmic Solution 0.5%

## Key facts

- **NCT ID:** NCT00293787
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2012-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00293787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00293787, "A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00293787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*